Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.
Frequently asked questions
What sector does Redsense Medical AB (REDS) operate in?
Redsense Medical AB belongs to the Other sector and operates in the Medical Devices industry.
What is Redsense Medical AB (REDS) current stock price?
As of the latest data, Redsense Medical AB stock price is SEK 4.01, with a previous close of SEK 3.90. Redsense Medical AB gained SEK 0.11 in the last trading session, representing a 2.82% increase.
What is Redsense Medical AB (REDS) current market capitalization?
Redsense Medical AB market cap is approximately 65.94 million.
What is Redsense Medical AB (REDS) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.18, and the forward EPS is SEK 0.10.
Does Redsense Medical AB (REDS) pay dividends?
No. Redsense Medical AB does not pay a dividend.
What is Redsense Medical AB (REDS) beta (volatility) score?
Redsense Medical AB has a beta of 0.435, indicating lower volatility than the overall market.